Physician profile
Travis Greer
NPI 1083811384
$6,846.98
in general payments reported to CMS, 2019-2025
36 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $162 · 2021: $326 · 2022: $1,268 · 2023: $217 · 2024: $4,471 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $595 · Travel and Lodging: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $595.13 |
| Travel and Lodging | $237.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,329.56 | 2024-2025 | |
| Electromed, INC. | $476.23 | 2021-2025 | Smartvest |
| Ethicon INC. | $370.37 | 2022 | |
| Philips North America LLC | $245.21 | 2019-2022 | |
| Glaxosmithkline, LLC. | $188.85 | 2019-2023 | Nucala |
| Astrazeneca Pharmaceuticals Lp | $186.06 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $150.89 | 2019-2023 | Uptravi |
| Inspire Medical Systems, INC. | $93.15 | 2023-2025 | Inspire |
| Sunovion Pharmaceuticals INC. | $89.64 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.91 | 2020-2022 | |
| Resmed Corp | $65.83 | 2019-2025 | |
| Genzyme Corporation | $60.87 | 2019-2022 | |
| Ambu INC. | $53.38 | 2025 | |
| Mylan Specialty L.P. | $42.06 | 2020-2022 | |
| Abbott Laboratories | $40.52 | 2023 | Freestyle Libre 3 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $32.49 | 2024 | Hemosphere |
| Gilead Sciences, INC. | $30.84 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $22.09 | 2022 | |
| Amgen INC. | $20.40 | 2022 | |
| Vapotherm INC | $20.34 | 2022 | |
| Alexion Pharmaceuticals, INC. | $19.94 | 2022 | |
| Tempus Ai, INC | $19.75 | 2025 | Xt Cdx |
| Takeda Pharmaceuticals U.S.A., INC. | $19.16 | 2020 | |
| Edwards Lifesciences Corporation | $18.99 | 2023 | Hemosphere |
| Bayer Healthcare Pharmaceuticals INC. | $18.69 | 2022 | |
| Conmed Corporation | $16.85 | 2024 | Fastrace |
| Mallinckrodt Hospital Products INC. | $16.58 | 2021 | |
| Pharming Healthcare, INC. | $16.38 | 2023 | Ruconest |
| Harmony Biosciences LLC | $16.24 | 2022 | |
| Abbvie INC. | $16.20 | 2021 | |
| Boston Scientific Corporation | $15.80 | 2022 | |
| Insmed, INC. | $14.24 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.10 | 2023 | Quviviq |
| Ekos Corporation | $12.53 | 2019 | |
| Pulmonx Corporation | $12.17 | 2020 | |
| Advanced Respiratory, INC | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.